Yifan Pharmaceutical Co Ltd
SZSE:002019
Intrinsic Value
Yifan Pharmaceutical Co., Ltd. engages in the research, development, production and sale of pharmaceutical products, active pharmaceutical ingredients and polymer materials. [ Read More ]
The intrinsic value of one Yifan Pharmaceutical Co Ltd stock under the Base Case scenario is 15.98 CNY. Compared to the current market price of 11.1 CNY, Yifan Pharmaceutical Co Ltd is Undervalued by 31%.
Valuation Backtest
Yifan Pharmaceutical Co Ltd
Run backtest to discover the historical profit from buying and selling Yifan Pharmaceutical Co Ltd stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Yifan Pharmaceutical Co Ltd
| Current Assets | 3.5B |
| Cash & Short-Term Investments | 982.8m |
| Receivables | 1.3B |
| Other Current Assets | 1.2B |
| Non-Current Assets | 9B |
| Long-Term Investments | 770.4m |
| PP&E | 1.7B |
| Intangibles | 6.2B |
| Other Non-Current Assets | 358.1m |
| Current Liabilities | 2.1B |
| Accounts Payable | 328.7m |
| Accrued Liabilities | 147m |
| Short-Term Debt | 677.1m |
| Other Current Liabilities | 912.1m |
| Non-Current Liabilities | 1.5B |
| Long-Term Debt | 965.7m |
| Other Non-Current Liabilities | 567.9m |
Earnings Waterfall
Yifan Pharmaceutical Co Ltd
|
Revenue
|
4B
CNY
|
|
Cost of Revenue
|
-2.1B
CNY
|
|
Gross Profit
|
1.9B
CNY
|
|
Operating Expenses
|
-1.8B
CNY
|
|
Operating Income
|
135.8m
CNY
|
|
Other Expenses
|
-890.4k
CNY
|
|
Net Income
|
134.9m
CNY
|
Free Cash Flow Analysis
Yifan Pharmaceutical Co Ltd
What is Free Cash Flow?
Profitability Score
Profitability Due Diligence
Yifan Pharmaceutical Co Ltd's profitability score is 46/100. The higher the profitability score, the more profitable the company is.
Score
Yifan Pharmaceutical Co Ltd's profitability score is 46/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Yifan Pharmaceutical Co Ltd's solvency score is 68/100. The higher the solvency score, the more solvent the company is.
Score
Yifan Pharmaceutical Co Ltd's solvency score is 68/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Yifan Pharmaceutical Co Ltd
According to Wall Street analysts, the average 1-year price target for Yifan Pharmaceutical Co Ltd is 16.42 CNY .
Shareholder Return
Price
Yifan Pharmaceutical Co Ltd
| Average Annual Return | -4.07% |
| Standard Deviation of Annual Returns | 21.69% |
| Max Drawdown | -71% |
| Market Capitalization | 13.3B CNY |
| Shares Outstanding | 1 218 798 158 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Yifan Pharmaceutical Co., Ltd. engages in the research, development, production and sale of pharmaceutical products, active pharmaceutical ingredients and polymer materials. The company is headquartered in Hangzhou, Zhejiang and currently employs 4,285 full-time employees. The company went IPO on 2004-07-13. The firm operates in three segments, including Pharmaceuticals, Pharmaceutical Raw Material and Intermediates, as well as Polymer Materials. The firm's main products include D-calcium pantothenate, D- panthenol, poly butylenes succinate and others. The firm distributes its products in domestic and overseas markets.
Contact
IPO
Employees
Officers
The intrinsic value of one Yifan Pharmaceutical Co Ltd stock under the Base Case scenario is 15.98 CNY.
Compared to the current market price of 11.1 CNY, Yifan Pharmaceutical Co Ltd is Undervalued by 31%.
You don't have any saved screeners yet
